Introduction of the NMDA receptors (Krupp et al., 1998; Villarroel et al., 1998) . L-glutamate, the major excitatory neurotransmitter in the In AMPA receptors, desensitization is modulated by brain, activates three distinct types of ionotropic recepalternative splicing and RNA editing of segments in S2. tors: N-methyl-D-aspartate (NMDA), ␣-amino-3-hydroxy-
The alternative spliced versions (known as "flip" and 5-methyl-4-isoxazole-propionate (AMPA), and kainate "flop") differ in their time course of desensitization and receptors (reviewed by Watkins and Evans, 1981; Col- in their sensitivity to the desensitization blocker cyclothilingridge and Lester, 1989; Monaghan et al., 1989) .
azide (Sommer et al., 1990; Mosbacher et al., 1994 ; Par-AMPA and kainate receptors desensitize completely tin et al., 1994) , and some of the molecular determinants and rapidly in response to glutamate, with a time confor these differences have been elucidated (Partin et al., stant of ‫5ف‬ ms (Mayer and Westbrook, 1987; Trussell 1995 Trussell , 1996 . The amino acid preceding the alternative and Fischbach, 1989; Jonas and Spruston, 1994; Trus- spliced flip and flop modules is subject to RNA editing, sell et al., 1994) . This profound desensitization, together and the edited channels possess faster recovery rates with slow recovery, is thought to play a role in determinfrom desensitization (R/G site; Lomeli et al., 1994) . Reing synaptic amplitudes, particularly during high frecently, it has also been demonstrated that residues at quency of release; at synapses with multiple release the N terminus of S2 modulate desensitization of GluR1 sites; at elevated synaptic activity, when clearance of (Mano et al., 1996) and GluR6 receptors (Swanson et glutamate is slowed; and during brain damage that al., 1997) . The role of S1 in the desensitization of AMPA receptors is unclear.
Although both AMPA and kainate receptors desensi- ‡ To whom correspondence should be addressed (e-mail: crosenm @gwdg.de).
tize upon continuous application of glutamate, specific kinetic parameters vary considerably. These include, first, the extent of desensitization produced by various agonists. For example, kainate produces apparent nondesensitizing currents at AMPA receptors, while it elicits completely desensitizing currents at kainate receptors. Second, the time course for recovery from desensitization is ‫05ف‬ times slower for the kainate receptors than for the AMPA receptors. Third, they have differential sensitivity to allosteric modulators. For example, Concanavalin A blocks desensitization at kainate receptors but is much less potent at AMPA receptors, while cyclothiazide blocks desensitization at AMPA receptors but has no effect on kainate receptors (reviewed by Bettler and Mulle, 1995) . Based on these differences, structural elements specific for AMPA and kainate receptor desensitization may reveal underlying mechanisms of channel gating. We thus analyzed the kinetic properties of the GluR3-GluR6 chimeras that were previously used to investigate receptor pharmacology (Stern-Bach et al., 1994) .
In the course of that study, we had identified certain chimeras that did not desensitize at all, while all other receptor channel properties remained intact. Following this unusual behavior, additional mutagenesis identified three regions in S1 of GluR3 that modified AMPA receptor desensitization, with a major role for L507, a residue contained in a structure controlling agonist binding. 1991; Colquhoun et al., 1992) in order to obtain solution (E) Current-voltage relationship of R3(R6S1) flip in outside-out patch exchanges faster than the rate of desensitization meaconfiguration. Voltage was ramped from Ϫ80 to ϩ20 mV at 1 mV/ sured for these glutamate receptors. Patches were exms. The trace represents an average of seven episodes in the presence of 10 mM glutamate after leak subtraction. Patch solutions posed to 0.5-2 s pulses of saturating glutamate concencontained no polyamines.
trations (10 mM). As shown in Figures 1A and 1B, (F) Dose-response relationship for L-glutamate for GluR3 flip (in pres- applying the agonist at a holding potential of Ϫ60 mV ence of 100 M cyclothiazide, white circles), R6TM1R3 flip (black evoked a rapidly evolving and strongly desensitizing squares), and R3(R6S1) flip (black triangles), recorded in a whole-cell inward current for both GluR3 and GluR6 homomeric mode. Currents were normalized to the response at 10 mM. EC 50 channels. The amount of desensitization, expressed as and hill slope values (n) were estimated by fitting the concentrationcurrent relationship with the equation Y ϭ 1/(1 ϩ [EC 50 /(Glu)]n) and the ratio of peak to steady-state amplitude (P/S) was were 148 M/1.95 for GluR3 flip , 155 M/n ϭ 1.66 for R6TM1R3 flip , 46.2 Ϯ 3.9 for GluR3 flip (n ϭ 13) and 236 Ϯ 53 for GluR6 navalin A (1 g/l), when added to the agonist solution of GluR3 flip or GluR6, respectively, resulting in P/S values close to one (data not shown). The rate of recovery from desensitization (R R ) was measured in paired pulse respectively). The kinetic characteristics of GluR3 flip and GluR6 are consistent with published values and are protocols and was ‫05ف‬ times faster for GluR3 flip than for GluR6 (29.9 Ϯ 7.1 s Ϫ1 and 0.57 Ϯ 0.06 s
Ϫ1
, n ϭ 10, comparable to native channels (Trussell et al., 1988; Sommer et al., 1990; Heckmann et al., 1996 ; Traynelis peak response of R6TM1R3 (n ϭ 13) and R3(R6S1) (n ϭ and Wahl, 1997). 10), respectively. This inhibition is similar to that obTo identify specific protein domains modulating reserved for AMPA receptors saturated with cyclothiazide, ceptor desensitization, responses to glutamate from after rapid removal of the drug from the external solution chimeric GluR3-GluR6 receptors were analyzed (Stern- (Partin et al., 1993 . Second, the steady-state am- Bach et al., 1994) . In contrast to both parent receptors, plitude of a desensitized AMPA receptor is in the range one N-terminal chimera, termed R6TM1R3 ( Figure 1C) , of 2.5% of the peak response. Assuming similar channel in which the entire extracellular N-terminal region of densities, the responses from the chimeric receptor GluR3 flip was substituted by the corresponding region should be quite small. However, patch responses were of GluR6, showed complete removal of desensitization 156 Ϯ 78 pA (n ϭ 30), ‫-31ف‬fold greater than the average (P/S ϭ 1.02 Ϯ 0.01, n ϭ 30; Figure 1C) . peak responses to GluR3 and ‫-3ف‬fold greater than reSeveral studies have indicated that AMPA receptor sponses of GluR3 when treated with cyclothiazide. desensitization is modulated by the "flip/flop" region Third, a desensitized receptor state should be reflective located in S2 (Sommer et al., 1990; Mosbacher et al., in its single channel behavior by either smaller conduc-1994; Partin et al., 1994 Partin et al., , 1995 . Analysis of the flop vertance states, shorter mean open times, or longer shut sion of chimera R6TM1R3 also showed complete retimes. On occasionally occurring patches that contained moval of desensitization (P/S ϭ 1.07 Ϯ 0.04, n ϭ 9; data only a single chimeric channel, the channel opened to an not shown), suggesting that the removal of desensitizaapparent 23 pS state, with a very high open probability tion does not require specific splice variants in the flip/ (88.3% Ϯ 5% at 10 mM glutamate), similar to the conflop cassette.
ductance behavior observed with GluR3 single channels Based on the homology to bacterial proteins and functreated with cyclothiazide (Rosenmund et al., 1998) . tional studies, the N-terminal region can be separated Finally, since S1 is exclusively located on the extracelin two, the LIVBP-like domain and the agonist binding lular site and is part of the ligand binding domain, mutadomain S1. These two regions were examined sepagenesis may influence agonist binding but not ion perrately by measuring the kinetic properties of chimera meation. Consistent with that, we found no obvious R3(R6S1), in which the GluR6 substitution was limited differences in the current voltage properties between to S1, and chimera R6KBPR3, in which it was limited to GluR3 flip and the chimeras R6TM1R3 and R3(R6S1) (Figthe LIVBP-like region. Chimera R3(R6S1) exhibited a ure 1E). Both chimeras responded to glutamate in a fully nondesensitizing response (P/S ϭ 1.01 Ϯ 0.01, n ϭ dose-dependent manner that was similar to that ob-6; Figure 1D ), whereas chimera R6KBPR3 resulted in a served for GluR3 flip ( Figure 1F ; see also Stern-Bach et al., receptor indistinguishable from GluR3 (P/S ϭ 56.2 Ϯ 22, 1994). As agonist potency strongly depends on receptor R D ϭ 232 Ϯ 44 s
, R R ϭ 19.3 Ϯ 5.2 s Ϫ1 , n ϭ 6; data not desensitization (Trussell and Fischbach, 1989; Patneau shown) . The LIVBP-like region was recently reported to and Mayer, 1990; Patneau et al., 1993; Yamada and affect glycine-independent NMDA receptor desensitizaTang, 1993; Partin et al., 1994) , we removed desensitization (Krupp et al., 1998; Villarroel et al., 1998) . To further tion of the native receptor GluR3 flip by coapplying the test its possible role in desensitization, we also checked desensitization blocker cyclothiazide. Based on the lack the kinetic properties of the reverse chimera R3KBPR6 of receptor desensitization, these measurements were and of chimera NR1KBPR6, in which the LIVBP-like docarried out in whole-cell recordings that allowed more main was taken from the NMDA receptor subunit NR1a accurate measurements of current amplitudes. Potency (Stern-Bach et al., 1994) . These two chimeras desensivalues obtained from patches showed identical values tized in a manner similar to GluR6 (R3KBPR6: P/S ϭ and were thus pooled. Interestingly, cyclothiazide re-94.3 Ϯ 23, R D ϭ 341 Ϯ 45 s Ϫ1 , R R ϭ 0.24 Ϯ 0.07 s Ϫ1 , duced glutamate potency from 155 M to 398 M for n ϭ 5; and NR1KBPR6: P/S ϭ 83.1 Ϯ 33, R D ϭ 411 Ϯ R6TM1R3 (n ϭ 5) and from 107 M to 199 M for 73 s Ϫ1 , R R ϭ 0.31 Ϯ 0.09 s Ϫ1 , n ϭ 4). Thus, abolishing R3(R6S1) (n ϭ 6). A similar reduction in affinity was desensitization in GluR3 by the chimeric exchange is observed for [ 3 H]AMPA binding to rat brain membranes exclusively a result of replacing the agonist binding dowhen treated with cyclothiazide (Kessler et al., 1996) . main S1.
Taken together, these results show that abolishing We excluded for three reasons the possibility that the desensitization in R6TM1R3 and R3(R6S1) does not reobserved lack of desensitization for chimeras R6TM1R3 sult in gross alteration of other receptor channel funcand R3(R6S1) could be due to some other form of kinetic tions. It also suggests that desensitization is an active change (for example, an increase of the desensitization gating process independent from the process of actirate to an extent that would impede detection in our vation. experiments), and thus, the receptor is being observed in its desensitized state. First, desensitization of AMPA Three Distinct Regions in S1 Modify Desensitization receptors can be blocked by cyclothiazide. Since both Properties of GluR3 Receptors chimeras carry the "GluR3-flip" region important for
The S1 region of GluR6 consists of 162 amino acids, cyclothiazide binding (Partin et al., , 1996 , any ocof which 79 are different from GluR3. To identify the cluded desensitization should be revealed by an inresidue(s) responsible for regulating desensitization, we crease of the peak response in the presence of this constructed 12 new "S1" chimeras, consisting of prodrug. However, the addition of 100 M cyclothiazide to gressively smaller and complementary GluR6 substituthe agonist solution (a concentration that increases peak tions (N1-N6 and C1-C6, Figure 2 ). All of the functional responses of GluR3 flip up to 3-fold, together with a com-C-terminal chimeras altered the desensitization properplete block of desensitization; Partin et al., 1994) resulted in a 14% Ϯ 4% and 12% Ϯ 3% inhibition of the ties of the GluR3 "parent." Chimeras C6, C5, C3, and C2 did not desensitize, while C1 was partially desensitizing desensitization of all of the C1a-C1d chimeras was statistically different (p Ͻ 0.05), suggesting that multiple ( Figure 2 ). The kinetics of C1 were significantly different from both GluR3 flip (p Ͻ 0.001) and C2 (p Ͻ 0.001), sugcombinations of mutations are required to produce the C1 phenotype. gesting that at least two sites within C2 modify desensitization.
In addition to the replacements made at the C terminus of S1, those made at the N terminus also modified The 34 amino acid region replaced in C1 is proposed to include one of the hinge regions connecting the two desensitization properties of GluR3 flip . Chimeras N2, N3, and N4 but not N6 exhibited significant reductions in agonist binding lobes (Stern-Bach et al., 1994; Sutcliffe et al., 1996; Swanson et al., 1997) and was recently found both desensitization and resensitization rates ( Figure 2 ). Thus, residues located in the region between R417 and to be involved in glycine-independent NMDA receptor desensitization (pre-M1; Krupp et al., 1998; Villarroel et Y474 may also be involved in desensitization. Further studies are required to evaluate their exact role. al., 1998). We further examined the role of the 12 residues in R3(R6S1C1) that are different from GluR3 by In summary, three distinct regions in S1 modify desensitization properties of GluR3 receptors. The first is situgrouping them into four different chimeras (C1a-C1d; Figure 2 ). In comparison to the C1 replacement, the ated between R417 and Y474 (a cross of N4 and N6 exchanges), the second between A501 and D514 (a cross of C2 and C1 exchanges), and the third between F515 and E548 (C1).
A Single Exchange in Proximity to Residues that Bind Glutamate Removes Desensitization of GluR3 Receptors
The region substituted in the C2 chimera, excluding C1 (i.e., A501-D514), contains only three amino acids that differ between GluR3 and GluR6. These are T504A, L507Y, and E511K ( Figure 3) . A simultaneous exchange of all three of these amino acids resulted in a barely desensitizing receptor ( Figure 3A ). The replacement of single amino acid residues within these positions reveals that L507Y accounted entirely for the removal of desensitization ( Figure 3B , middle). Its effect was slightly reduced when combined with E511K ( Figure 3B , right) but not with T504A ( Figure 3B , left). In addition to glutamate, quisqualate (1 mM; P/S ϭ 1.03 Ϯ 0.06, n ϭ 34) or AMPA (1 mM; P/S ϭ 1.05 Ϯ 0.03, n ϭ 24) also elucidated nondesensitizing responses, with an identical efficacy of opening as glutamate (glutamate/quisqualate ϭ 1.02 Ϯ 0.02 and glutamate/AMPA ϭ 0.97 Ϯ 0.03, n ϭ 7, respectively). Desensitization was also abolished by the L507Y mutation when introduced into the flop version of GluR3 (P/S ϭ 1.01 Ϯ 0.04, n ϭ 12; data not shown). In contrast to the L507Y exchange, T504A, E511K, or their combined exchange had no effect on the desensitization rate ( Figure 3C ) nor on the resensitization properties of GluR3 flip (data not shown). Moreover, desensitization of these three later mutants was completely blocked by cyclothiazide (100 M). In contrast, cyclothiazide reduced peak response of L507Y by 9.6% Ϯ 2.7% and reduced the affinity for glutamate from 48 to 262 M (n ϭ 6), similar to what was observed for the nondesensitizing chimeras R6TM1R3 and R3(R6S1). Interestingly, we found that all mutants containing the T504A exchange evoked a weak response to 10 mM glutamate-usually a saturating concentration (GluR3 flip receptors; Figure 1F ). Responses evoked by quisqualate (1 mM) applied to the same patch were usually about 3-fold greater than the response evoked by 10 mM glutamate (see Figure 3D) . The difference between glutamate for agonist binding (Uchino et al., 1992) , we tested (B) Representative responses from receptors containing the L507Y whether a change in glutamate efficacy or affinity had mutation alone (middle, P/S ϭ 1.01 Ϯ 0.01, n ϭ 12) or in combination occurred. Dose-response analysis revealed that all muwith T504A (left, P/S ϭ 1.09 Ϯ 0.04, n ϭ 8) or E511K (right, P/S ϭ 2.1 Ϯ 0.14; R D ϭ 8.6 Ϯ 0.45 s Ϫ1 ; n ϭ 21).
tants containing the T504A substitution exhibited a less ; n ϭ 11), or combined (middle, P/S ϭ 30.7 Ϯ 7.2; R D ϭ 186 Ϯ 43 s Ϫ1 ; n ϭ 9). All receptors were activated by 10 mM glutamate, except for those containing the T504A mutation, where a concentration 90 mM has been used. (D) Superimposed responses from a patch containing R3(T504A) to measured as described in Figure 1F ; desensitizing receptors were 1 mM quisqualate and 10 mM and 90 mM glutamate as indicated. measured in the presence of 100 M cyclothiazide. EC 50 and hill L-quisqualate-(1 mM) induced desensitization was similar to desenslope values (n) were L507Y (-Y-) ϭ 48 M/n ϭ 1.66, L507Y ϩ E511K sitization evoked by glutamate (P/S ϭ 24.0
L507Y (AY-) ϭ 2.09 mM/n ϭ 1.64, T504A ϩ L507Y ϩ E511K (AYK) ϭ (E) Dose-Response relationships to glutamate of the mutants shown 9.6 mM/n ϭ 1.48, T504A (A-) ϭ 19.9 mM/n ϭ 1.81, and T504A ϩ in (A) through (C) (indicated by letter code on each trace) were E511K (A-K) ϭ 21.2 mM/n ϭ 1.81.
Y521 to glycine (n ϭ 7), valine (n ϭ 4), and glutamate (n ϭ 4) resulted in desensitization properties indistinguishable from GluR6 wild-type (data not shown). Therefore, this particular site (R3-507/R6-521) appears to be specific for AMPA but not kainate receptor desensitization. The N1 replacement (Figure 2) , which includes the L507Y mutation, resulted in a partially desensitizing receptor, similar to that found in the double mutation L507Y ϩ E511K, compared with L507Y alone ( Figure  3B , right versus middle). Thus, the control of desensitization by position 507 either may be modulated by other residues, or position 507 is necessary but not specific for the control of desensitization. To test this, we first measured the effect of a reversed Y-to-L mutation on the nondesensitizing R6TM1R3 chimera (see Figure 1C) . The resulting R6TM1R3(Y521L) receptor gained back almost complete desensitization but with a 16-fold slower rate (R D ϭ 15.4 Ϯ 1.1 s Ϫ1 ; P/S ϭ 11.5 Ϯ 2.1, n ϭ 8; Figure 4C ). Desensitization was blocked by cyclothiazide ( Figure 4D ), and resensitization was not different compared with GluR3 flip (R R ϭ 14.2 Ϯ 4.2 s Ϫ1 , n ϭ 3), suggesting that the kinetic characteristics of mutant R6TM1R3(Y521L) resemble those of GluR3. interaction observed between these two sites could thus be explained by either specific interactions between the response amplitude of quisqualate ( Figure 3D ), indipositions 511 and 507 or by the entire ␣ helix nonspecificating that the efficacy of channel opening was not afcally controlling desensitization. We therefore tested fected by the mutation T504A.
whether a tyrosine residue at position 511 will also reThe effects on glutamate potency of both positions sult in a nondesensitizing receptor. However, mutant T504A and L507Y were independent of each other, as R3(E511Y) exhibits desensitization properties characthe introduction of the T504A mutation led to a parallel teristic of the wild-type receptor (P/S ϭ 43.9 Ϯ 13; R D ϭ reduction of potency (Y Ͼ AY ϭ 44-fold; YK Ͼ AYK ϭ 383 Ϯ 50 s Ϫ1 ; R R ϭ 27.9 Ϯ 8.0 s Ϫ1 , n ϭ 4; data not 73-fold; K Ͼ AK ϭ 90-fold; Figure 3E ), suggesting that shown). Taken together, we can conclude that L507 is the mechanisms of the affinity shift were independent.
specifically required for AMPA-type receptor desensitiIn summary, the mutations in the region T504-E511 rezation to occur but with an additional modulatory effect veal an intriguing convergence of agonist binding and of surrounding residues on this position. receptor desensitization.
Specificity of Position L507 to AMPA Removal of Desensitization Requires the Exchange of L507 to an Aromatic Residue Receptor Desensitization
The AMPA receptor subunits GluR1-GluR4 share high
To understand the nature of the removal of desensitization by the L507Y mutation, we introduced residues sequence homology in the S1 region (Ͼ85%), suggesting that a leucine-to-tyrosine exchange on other other than tyrosine in this position ( Figure 5) . Of the 11 mutations tested, desensitization was blocked by three AMPA receptor subunits as well as in native AMPA receptors would lead to the same phenotype. We tested changes, to phenylalanine (F; P/S ϭ 1.08 Ϯ 0.11, n ϭ 7; Figures 5A and 5D ), tryptophan (W; P/S ϭ 1.01 Ϯ this by mutating position L497Y on GluR1 flip , the subunit that shares the least homology with GluR3 flip . This mutant 0.03, n ϭ 5; Figure 5D ), and histidine (H; P/S ϭ 2.03 Ϯ 0.4, n ϭ 6; Figure 5D ), all aromatic. The partial desensitization also resulted in a complete block of desensitization (Figure 4A) .
observed for mutation L507H may be due to the slightly smaller size of the imidazole ring rather than its protonTo further test the specificity of site L507, we performed a reverse mutation on the kainate receptor ation state, since we observed similar behavior at different pH values (data not shown). Exchanges to the aliGluR6. Mutant R6(Y521L) was almost identical in its kinetics when compared with the wild-type GluR6 recepphatic alcohol side chains serine (S; Figure 5B ) and threonine (T; Figure 5C ) resulted in fully desensitizing tor ( Figure 4B ). This result implies that Y521 is not involved in kainate receptor desensitization, although it receptors, with a significant faster desensitization rate, R D , for the L507T. A similar increase was also observed was possible that a change to something other than leucine might have an effect. However, mutations of by the mutation to asparagine (N; Figure 5D ). Finally, glutamate-induced desensitization ( Figure 6A ). The fully desensitizing receptors exhibited a peak glutamate/kainate response ratio (G/K) of 53.2 Ϯ 5.3 (n ϭ 55), while kainate were now apparent (P/S ϭ 2.71 Ϯ 0.2; R D ϭ 155 Ϯ 28 s Ϫ1 ; n ϭ 6; Figure 6B ). Similar results were obtained from chimeras N1-N3 (n ϭ 21; Figure 2 and exchanges to the basic/positively charged lysine (K), data not shown), indicating the validity of this aforemenacidic/negatively charged glutamate (E), or to the relationed hypothesis. As kainate responses evoked on tively small side chains valine (V) and glycine (G) had no AMPA receptors appear rapidly desensitizing and reapparent effect on desensitization when compared with spond comparably as well as glutamate to the removal GluR3 flip ( Figure 5D ). of desensitization by the S1 chimeras, the conformations the receptor undergoes upon agonist binding ocKainate Elicits Fast Desensitizing Currents curs regardless of which agonist is used. Differences in at AMPA Receptors respect to the agonist may be the speed of the desensiti-A structural tie between agonist binding and desensitization process, however. zation could be the basis for the observation that AMPA receptor desensitization depends on the agonist used. Kainate applied to AMPA receptors induces rapid, much Discussion weaker desensitizing responses, with considerably lower agonist efficacy than AMPA or glutamate (Patneau and The process of glutamate receptor desensitization is thought to be coupled to binding of the agonist. HowMayer, 1991; Patneau et al., 1993) . If kainate binding and activation induce conformational changes other than ever, little is known about the structures and mechanisms underlying the gating process. By following the those induced by glutamate (particularly the one associated with desensitization), the degree of glutamateabnormal nondesensitizing behavior of a chimeric GluR3-GluR6 receptor, we were able to detect a single mutainduced desensitization expressed by a receptor should not influence its kainate response. Responses evoked tion, L507Y, that abolished GluR3 receptor desensitization. L507 resides in between two residues that are by saturating kainate concentrations (5-10 mM) from the GluR3-S1 chimeras (see Figures 1 and 2 ) were all involved in glutamate binding, T504 and R509. Moreover, an identical mutation made on GluR1, another essentially nondesensitizing. The efficacy of kainate was maximal for nondesensitizing receptors and was posi-AMPA receptor subunit, also resulted in a nondesensitizing receptor. In contrast, the corresponding reverse tively correlated (r ϭ 0.91) to the degree of inhibition of mutation, Y521L, made on the kainate receptor GluR6, al., 1993) . Our results further support this observation. In general, responses to kainate from chimeras that were had only a marginal effect on receptor desensitization.
Two conclusions can be drawn based on these renondesensitizing had a higher efficacy compared with responses evoked by desensitizing receptors, suggestsults. First, our data directly link the conformational change induced by the binding of the agonist to both ing that kainate efficacy is correlated with the degree of receptor desensitization. The maximal efficacy of kaiactivation and desensitization, since we observed three intertwined residues on one secondary structure elenate we observed was in the range of 25%, however. Furthermore, using the 16-fold slower but fully desensiment that independently control agonist binding and desensitization. Following binding, activation and detizing chimera R6TM1R3(Y521L), kainate-induced desensitization became more apparent ( Figure 6B) . Thus, sensitization then proceed in two independent and separable conformational changes. Second, the relatively it is likely that the differences in desensitization rates observed for kainate versus glutamate are based on the clean separation of desensitization without or only mildly affecting binding or activation suggests that activation, ability of kainate-activated AMPA receptors to make the desensitization process more rapid, and thus, to make but not desensitization, is a conserved process within the glutamate receptor family. Since site L507 was found it hard to detect. This may suggest that the first step required for the desensitized state occurs as fast as to be required for AMPA but not kainate receptor desensitization, AMPA and kainate receptors probably have binding and possibly faster than activation. unique structural motifs that shape their desensitization properties.
Structural Elements Unique for AMPA Receptor Desensitization Both GluR6 and GluR3 receptors desensitize rapidly and Technical Limitations of Mapping Structures to Measurements of Desensitization
almost completely in response to glutamate. The conservative mutational analysis we have employed screens Two main problems arise in studying the molecular events underlying AMPA receptor channel desensitizafor structural motifs that are unique for both receptors. This was shown most dramatically with the identification. A mutational approach generates uncertainty over how mutations to single residues or segments affect the tion of position L507. Contrary to the corresponding position 521 in GluR6 receptors, L507 was required and structure of the receptor in general. However, we believe this is a minor problem in our study. Chimeric exchanges sufficient to control AMPA receptor desensitization. The specific phenotypes observed with the L507 mutations between AMPA and kainate receptors represent conservative mutations, as both receptors share high sequence and the rescue of AMPA-like desensitization with chimera R6TM1R3(Y521L) indicate a major role of this resihomology. We observed no drastic changes whether only the residue L507 or the entire N-terminal part of due in the process of AMPA but not kainate receptor desensitization. In support of this, L507 is conserved for the protein has been exchanged with GluR6 residues. In addition, the apparent nondesensitizing behavior did all AMPA receptors, while in kainate receptors, GluR5/6 contains a tyrosine in the corresponding position 521 not alter other receptor channel properties. On the other hand, a major limitation of the "chimeric" approach is and GluR7 contains a histidine. This hypothesis that AMPA and kainate receptors exhibit unique structural that structures controlling desensitization that are common to both receptors will not be detected. For example, elements awaits proof, however. Data obtained using a complementary approach to kainate receptor desensitithe modest effect (compared with L507Y) observed by the replacements made N-and C-terminal to L507 (i.e., zation may provide an answer. Another region, R417-Y474 (as defined by the chime-N2, N3, N4, and C1; Figure 2 ) may be due to highly conservative changes, and thus specific residues in ras N2-N4 versus N6; Figure 2 ), seems to contain structures unique for the extremely slow recovery from dethese positions may have a more important role in desensitization than we observed.
sensitization of kainate receptors, as the introduction of this segment in AMPA receptors significantly slowed Another problem arises from the methods we used to detect desensitization. An accurate measurement reresensitization rates (Figure 2 ). The underlying mechanism requires more detailed examination. Moreover, the quires that channel activation occur much faster than the rate of desensitization. Although a fast flow system exchange of this region also significantly reduced the rate of desensitization. As with the region surrounding with solution exchange times of 300 s and high agonist concentrations were used, one cannot exclude that the L507, it contains residues that line the agonist binding pocket (e.g., T423-S427 and D471-Y474), further suprate of desensitization exceeds activation. However, in all cases where single channels from nondesensitizing porting the close molecular tie between agonist binding and desensitization. Additional mutagenesis is required receptors could be observed (n ϭ 34), the same large conductance sizes (23 pS) and high open probability to identify the specific sites involved. Previous mutational studies indicated other regions ‫)%09ف(‬ at high agonist concentrations were seen. Therefore, gating modes carrying larger currents, as has that are involved in AMPA/kainate receptor desensitization. Mutations of residue S650 at the N terminus of S2 been observed for the steady-state response of the nondesensitizing receptors, are unlikely.
in GluR1 (Mano et al., 1996) and the corresponding site A689 of GluR6 (Swanson et al., 1997) have been shown The problem of detection is more apparent for the interpretation of kainate-induced currents. It was preto change desensitization properties. However, a similar mutation (S680A) made on GluR3 or on the nondesensiviously shown that kainate can evoke very rapidly desensitizing responses at AMPA receptors (Patneau et tizing R3(L507Y) had no effect on their kinetic properties (P/S ϭ 49.9 Ϯ 17, n ϭ 5 and P/S ϭ 1.05 Ϯ 0.02, n ϭ 5, respectively). Another study on the mechanism of cyclothiazide, an allosteric modulator that blocks AMPA but not kainate receptor desensitization, suggests some common form of desensitization. A serine residue in position S780 (S750 in GluR1 flip ), part of the flip/flop module (see Figure 7) , is required for the block of desensitization by cyclothiazide . It was further shown that the introduction of serine in the corresponding position of GluR6 enabled modulation by cyclothiazide. NMDA receptors also desensitize upon application of glutamate, although on a different time scale and involving multiple mechanisms. Using homologous exchanges between the desensitizing NR2A subunit and the nondesensitizing NR2C subunit, it has been recently found that glycine-independent desensitization of NMDA receptors is controlled by two distinct domains, one adjacent and preceding the binding domain S1 (the LIVBP-like region, pre-S1) and another immediately preceding M1 (pre-M1; Krupp et al., 1998; Villarroel et al., 1998) . A role for the pre-S1 region in AMPA receptor desensitization was not apparent in our study. The complementary exchanges of this region between GluR3 and GluR6, or even with the NMDA receptor subunit desensitization. Segment N6 contains the site corresponding to L507 in GluR3, and module 5 is located at activation, while additional interaction with lobe 2 causes the N terminus of S2. channel desensitization. However, L507 is part of a short The modulation we observed in the C1 region of GluR3 ␣ helix within lobe 1 (Figure 7) , positioned on the surface (pre-M1 of NMDA receptors) is complex and involves and close and opposite to the residues involved in agomultiple substitutions (Figure 2 ). Significant changes in nist binding (T504 and T509), arguing strongly that agothe P/S ratio rather than the desensitization rate were nist binding initiates the desensitization process within observed. However, in contrast to the NMDA receptors, lobe 1. the replacement of small subsets of residues was not The movement of L507 during binding (perhaps tosufficient in modulating desensitization. Together with gether with structures within R417-Y474) may therefore the ‫-01ف‬fold difference in desensitization rates, proposbe the first in the cascade of conformational changes ing a common mechanism for pre-M1 and C1-like deleading to desensitization. The subsequent changes sensitization would be premature. Resolution of the may be within the subunit monomer and/or involve three-dimensional structure awaits to clarify the situneighboring subunits forming the oligomeric receptor ation.
channel complex. Such interactions could be confined to lobe 1, between lobes 1 and 2, or between lobe 1 and another unknown structure. Currently, most elements The Role of L507 in AMPA Receptor Desensitization found to affect desensitization are contained within lobe Based on homology to the bacterial PBPs and subse-1. The N-terminal region of S1 (R417-Y474) modulated quent experimental data, current structural models sugde-and resensitization rates, and the C1 segment tragest that the glutamate binding domain is formed by versing toward lobe 2 and the membrane affected the two lobes that bind the agonist molecule between them extent of desensitization. The flip/flop module, connect- (Stern-Bach et al., 1994; Paas et al., 1996; Sutcliffe et ing lobe 1 to the membrane, regulates recovery, desensial., 1996; Swanson et al., 1997) . S1 and the C-terminal tization rates, and modulation by the desensitization half of S2 form the larger lobe 1, while the N-terminal blocker cyclothiazide. half of S2 forms the smaller lobe 2 (see Figure 7) . AcAs L507 is proposed to be on the surface of lobe 1 cording to the proposed "Venus flytrap" model (Mano pointing away from the center, the current structural et al., 1996) , the agonist binds first to lobe 1, establishing models cannot predict the segment(s) that interacts with an "open-bound" configuration, and then interacts with L507. The observation that the reverse mutation Y-to-L lobe 2, forming the "closed-bound" configuration. The on the nondesensitizing chimera R6TM1R3 restored desensitization almost completely suggests that L507 has open-bound form has been proposed to induce channel to interact with residues C-terminal to it, assuming a by our mutations (Rosenmund et al., 1998 and unpublished data) , we favor a model in which the mutations yet unproven intrasubunit interaction. Candidate amino acids may be those found at the N terminus of S2 forming at site L507 prevent entry into the desensitized state. Taking into account the ‫-3ف‬fold reduction in glutalobe 2 or in the flip/flop region contained in lobe 1. However, none of these structures seems to interact mate affinity by cyclothiazide, as observed for the nondesensitizing mutants and in binding studies (Kessler directly, based on predicted long distances to L507 (see Figure 7) . et al., 1996) , the actual EC 50 value for wild-type GluR3 flip (compared with the measured 148 M) could be very Two other possibilities exist. First, one could speculate that L507 (alone or in concert with other residues) similar to that obtained for the point mutant R3(L507Y) (48 M). In this respect, the effect of removal of desensiinteracts directly with the conduction pathway, as the orientation of the lobes relative to the membrane is not tization by the drug at the glutamatergic synapse may be underestimated. Besides a reported action of cycloyet defined. An analogy may be found in the ␣7 nicotinic receptor, where a leucine ring in the transmembrane thiazide on release (Diamond and Jahr, 1995) , an increased efficacy of opening based on the removal of domain is thought to control agonist-dependent desensitization (Labarca et al., 1995) . Alternatively, L507 may desensitization could be offset by a reduction of receptor affinity, particularly in synapses that show a low interact with L507 (or another residue(s) located on neighboring subunits, as they may have close contact degree of postsynaptic receptor saturation. at this position. An aromatic bulky residue at this position may destabilize the oligomeric interaction and thus Concluding Remarks hinder conformational processes underlying desensitiFollowing abnormal behavior of chimeric AMPA/kainate zation. This is supported by the orientation of residue receptors, we were able to identify critical residues for S780 (S750 in GluR1 flip ), found to be critical for cyclothia-AMPA receptor desensitization. Our results also provide zide binding. S780 is facing the same direction as L507 a strong molecular basis for the hypothesis that receptor (Figure 7) , and it was proposed that cyclothiazide might desensitization is directly linked to agonist binding. bind between subunits to accomplish its action on deApplying a similar mutagenesis approach on GluR6 may sensitization .
further extend our knowledge of the mechanisms of glutamate receptor desensitization. Glutamate receptor stripped of desensitization may Desensitization, Open Probability, serve as a biosensor for glutamate concentrations (snifand Agonist Affinity fer patch) in screening for neuroprotective and nootropic Our present results, together with our recent discovery drugs, and it provides a powerful tool for investigating that single channel conductance is controlled by the receptor channel properties masked so far by the fast number of activated subunits (Rosenmund et al., 1998) , onset of receptor desensitization. For example, by indirectly suggest that desensitization controls the effistudying the single channel properties of the nondesencacy of channel opening and dissociation kinetics. As sitizing chimera R6TM1R3, we were able to detect three full conductance is reached by the concerted activation conductance states that depend on the number of agoof four subunits, activation kinetics (that are agonist nists bound, a finding that led us to propose that glutaconcentration-dependent) compete with the ongoing mate receptors are tetramers (Rosenmund et al., 1998) . desensitization kinetics, with the result that a higher concentration of agonists are needed to reach the maxiExperimental Procedures mum current. In experiments done with single channels of the nondesensitizing receptor R6TM1R3 (Rosenmund
Construction of Chimeras and Mutants
et al., 1998), following removal of the agonist, we obChimeras N1-N6 and C1-C6 were made as previously described (Stern-Bach et al., 1994) . Point mutations were synthesized by the served latencies for the switch from the large, fully occu-PCR-based method described by the QuickChange mutagenesis pied conductance state to smaller conductances that (Stratagene) . All mutants were first subcloned by an appropriate were longer than predicted (C. R., unpublished data). digest in GluR3 flip -pGEMHE and subsequently moved into pCDNA3
We interpret these slowed "dissociation kinetics" as affinity either by mutation of site 507 or by coapplication of cyclothiazide as well as the slowed current deactivaElectrophysiology tion upon removal of desensitization (Patneau et al., Outside-out patches were obtained from the human embryonic cell 1993; Yamada and Tang 1993; Partin et al., 1994) . In the line HEK293 (ATCC), expressing homomeric channels composed of ␣7 nicotinic receptors, mutations that reduce desensitirat GluR3 flip , GluR6 R , or chimeras 12-96 hr after transfection by the Ca 2 (PO 4 ) 3 -method (Chen and Okayama, 1988) . Transfected cells zation also result in an apparent increased affinity for were detected as described (Margolskee et al., 1993) . All kinetic agonists (Revah et al, 1991; Bertrand et al., 1992) . Since measurements were obtained from outside-out patches to maximize an 80 pS state was observed in addition to the original solution exchange rates. After excision of the patch, the patch was 45 pS, the apparent increase in affinity has been exmoved into a stream of a rapid perfusion system (Clements and plained by making the desensitized state permeable by Westbrook, 1991; Colquhoun et al., 1992 (1996) . The impact of receptor HEPES, 10 mM NaCl, and 10 mM EGTA, adjusted to 305 mOsm (pH desensitization on fast synaptic transmission. Trends Neurosci. 19, 7.3). Holding potential was usually Ϫ60 mV. Currents were amplified 96-101. with an Axopatch amplifier 200 B (Axon Instruments), filtered at Kessler, M., Arai, A., Quan, A., and Lynch, G. (1996) . Effect of cyclo-1-10 kHz, and digitized at 2-20 kHz with the pClamp 6.0 (Axon thiazide on binding properties of AMPA-type glutamate receptors: Instruments) acquisition system. The extracellular medium conlack of competition between cyclothiazide and GYKI 52466. Mol. tained 170 mM NaCl, 10 mM HEPES, 2-4 mM CaCl 2 , and 2-4 mM Pharmacol. 49, 123-131. MgCl 2 , adjusted to 330 mOsm (pH 7.25). Agonist solutions were Krupp, J.J., Vissel, B., Heinemann, S.F., and Westbrook, G.L. (1998). made by mixing external medium with isotonic (330 mOsm [pH 7.3] ) N-terminal domains in the NR2 subunit control desensitization of agonist stock solutions by replacing NaCl with the agonist. Analysis NMDA receptors. Neuron 20, 317-327. was performed with Axograph 3.5 software, and exponentials were Labarca, C., Nowak, M.W., Zhang, H., Tang, L., Deshpande, P., fitted by the squared error method. Multiple measurements from and Lester, H.A. (1995) . Channel gating governed symmetrically by one patch were averaged, and the results were treated as one experconserved leucine residues in the M2 domain of nicotinic receptors. iment. The significance of results was determined by analysis of Nature 376, 514-516. variance followed by Dunns posthoc comparison and are indicated Laube, B., Hirai, H., Sturgess, M., Betz, H., and Kuhse, J. (1997) . when p Ͻ 0.05.
Molecular determinants of agonist discrimination by NMDA receptor subunits: analysis of the glutamate binding site on the NR2B subunit.
